reboxetine has been researched along with Memory Disorders in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caso, JR; García-Bueno, B; González-Prieto, M; Gutiérrez, IL; Leza, JC; Madrigal, JLM | 1 |
| Chiu, GS; Freund, GG; Gainey, SJ; Kaczmarczyk, MM; Kelley, KW; Kwakwa, KA; Lawson, MA; Machaj, AS; Martin, SA; Meling, DD; Miller, MJ; Newman, AF; Wang, Y; Woods, JA; York, JM | 1 |
| Born, J; Diekelmann, S; Pommer, J; Rasch, B | 1 |
| Drugan, RC; Warner, TA | 1 |
| Amore, M; Di Sarro, R; Gallassi, R; Morreale, A | 1 |
2 trial(s) available for reboxetine and Memory Disorders
| Article | Year |
|---|---|
Pharmacological REM sleep suppression paradoxically improves rather than impairs skill memory.
Topics: Adolescent; Adrenergic Uptake Inhibitors; Adult; Affect; Association Learning; Catecholamines; Cross-Over Studies; Double-Blind Method; Electroencephalography; Fluvoxamine; Humans; Hydrocortisone; Male; Memory Disorders; Morpholines; Motor Skills; Neuropsychological Tests; Photic Stimulation; Reaction Time; Reboxetine; Selective Serotonin Reuptake Inhibitors; Sleep, REM; Surveys and Questionnaires; Young Adult | 2009 |
Memory impairment in patients with late-onset major depression: the effect of antidepressant therapy.
Topics: Adolescent; Adult; Age of Onset; Depressive Disorder, Major; Female; Fluoxetine; Humans; Male; Memory Disorders; Middle Aged; Morpholines; Neuropsychological Tests; Reboxetine; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index | 2006 |
3 other study(ies) available for reboxetine and Memory Disorders
| Article | Year |
|---|---|
Reboxetine Treatment Reduces Neuroinflammation and Neurodegeneration in the 5xFAD Mouse Model of Alzheimer's Disease: Role of CCL2.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Animals; Apoptosis; Axons; Biomarkers; Chemokine CCL2; Cyclooxygenase 2; Disease Models, Animal; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Inflammation; Memory Disorders; Mice, Inbred C57BL; Mice, Transgenic; Microglia; Nerve Degeneration; Reboxetine | 2019 |
Methylphenidate prevents high-fat diet (HFD)-induced learning/memory impairment in juvenile mice.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Antidepressive Agents; Anxiety; Blood Glucose; Body Weight; Brain-Derived Neurotrophic Factor; Central Nervous System Stimulants; Cerebral Cortex; Cytokines; Desipramine; Dietary Fats; Dopamine; Exploratory Behavior; Gene Expression Regulation; Hippocampus; Homovanillic Acid; Indoleamine-Pyrrole 2,3,-Dioxygenase; Learning Disabilities; Male; Maze Learning; Memory Disorders; Methylphenidate; Mice; Mice, Knockout; Monoamine Oxidase; Morpholines; Motor Activity; Overnutrition; Physical Endurance; Reboxetine; Receptors, Interleukin-1 Type I; Recognition, Psychology | 2013 |
Morris water maze performance deficit produced by intermittent swim stress is partially mediated by norepinephrine.
Topics: Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adrenergic Uptake Inhibitors; Analysis of Variance; Animals; Clonidine; Desipramine; Hippocampus; Learning; Male; Maze Learning; Memory Disorders; Morpholines; Norepinephrine; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reboxetine; Swimming | 2012 |